Depreciation, Depletion and Amortization of Coherus Oncology, Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Coherus Oncology, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • Coherus Oncology, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Dec 2025 was $300,000, a 200% increase year-over-year.
  • Coherus Oncology, Inc. Depreciation, Depletion and Amortization for the twelve months ending 31 Dec 2025 was $1,300,000, a 19% decline year-over-year.
  • Coherus Oncology, Inc. annual Depreciation, Depletion and Amortization for 2025 was $1,300,000, a 19% decline from 2024.
  • Coherus Oncology, Inc. annual Depreciation, Depletion and Amortization for 2024 was $1,600,000, a 11% decline from 2023.
  • Coherus Oncology, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1,800,000, a 50% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Coherus Oncology, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,300,000 $300,000 +$200,000 +200% 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $1,100,000 $300,000 -$100,000 -25% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,200,000 $300,000 -$200,000 -40% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,400,000 $400,000 -$200,000 -33% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,600,000 $100,000 +$800,000 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $800,000 $400,000 -$400,000 -50% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $1,200,000 $500,000 -$300,000 -38% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $1,500,000 $600,000 -$300,000 -33% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $1,800,000 $700,000 01 Oct 2023 31 Dec 2023 8-K 13 Nov 2025
Q3 2023 $800,000 -$100,000 -11% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $800,000 -$100,000 -11% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $900,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $900,000 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $900,000 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q2 2015 $1,059,000 $400,000 +$269,000 +205% 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $790,000 $232,000 +$116,000 +100% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $674,000 $235,000 01 Oct 2014 31 Dec 2014 10-K 23 Mar 2015 2014 FY
Q3 2014 $192,000 +$91,000 +90% 01 Jul 2014 30 Sep 2014 10-Q 15 Dec 2014 2014 Q3
Q2 2014 $131,000 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $116,000 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q3 2013 $101,000 01 Jul 2013 30 Sep 2013 10-Q 15 Dec 2014 2014 Q3

Coherus Oncology, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,300,000 -$300,000 -19% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $1,600,000 -$200,000 -11% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $1,800,000 -$1,800,000 -50% 01 Jan 2023 31 Dec 2023 8-K 13 Nov 2025
2022 $3,600,000 +$100,000 +2.9% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $3,500,000 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2024 2023 FY
2014 $674,000 +$270,000 +67% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2015 2014 FY
2013 $404,000 +$183,000 +83% 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
2012 $221,000 01 Jan 2012 31 Dec 2012 10-K 23 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.